Investors

Shareholder Tools

 

News & Events

Featured Event
Nov 10, 2009
9:00 AM ET
Corporate Update
Webcast Listen to webcast

Upcoming Events
Details on upcoming events are not yet available. Please click here to be notified of all upcoming events.

Archived Events
Dec 30, 2009
10:00 AM PT
Special Meeting of Stockholders
HTML file Proxy Materials
Show Additional Information
Oct 29–Nov 1, 2009 IDSA 47th Annual Meeting
PDF View Presentation 100.5 KB   Add to Briefcase
Apr 22–26, 2009 Annual Meeting of the European Association for the Study of the Liver
PDF View Presentation 158.3 KB   Add to Briefcase
Show Additional Information

Add to Briefcase = add file to Briefcase
All Releases
View Summary Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)
Feb 8, 2010
PDF 10.0 KB Add to Briefcase
View Summary Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infection
Jan 26, 2010
PDF 10.6 KB Add to Briefcase
View Summary Dynavax Expands Commercial and Clinical Leadership
Jan 12, 2010
PDF 10.0 KB Add to Briefcase
View Summary Dynavax Completes Symphony Dynamo Acquisition
Jan 4, 2010
PDF 10.1 KB Add to Briefcase
View Summary Dynavax's European Manufacturing Facility Approved for Commercial Production of HEPLISAV Hepatitis B Surface Antigen
Dec 9, 2009
PDF 9.6 KB Add to Briefcase
View Summary Dynavax Completes Enrollment of First Cohort of Patients in Phase 1b Clinical Trial for Hepatitis B Therapy
Nov 19, 2009
PDF 8.2 KB Add to Briefcase
View Summary Dynavax to Acquire Symphony Dynamo, Inc., Including $20 Million in Unrestricted Cash
Nov 10, 2009
PDF 12.0 KB Add to Briefcase
View Summary Dynavax Appoints Francis R. Cano, Ph.D. to Board of Directors
Nov 5, 2009
PDF 7.6 KB Add to Briefcase
View Summary Dynavax's HEPLISAV Shows Increased Protection Rate for Chronic Kidney Disease Patients
Oct 29, 2009
PDF 13.1 KB Add to Briefcase
View Summary Dynavax Announces Third Quarter 2009 Financial Results
Oct 22, 2009
PDF 22.1 KB Add to Briefcase
View Summary Dynavax to Report Third Quarter 2009 Financial Results after Market Closes on October 22, 2009
Oct 21, 2009
PDF 7.6 KB Add to Briefcase
View Summary Dynavax to Present at the Oppenheimer Healthcare Conference
Oct 20, 2009
PDF 7.6 KB Add to Briefcase
View Summary Dynavax Initiates Phase 3 Registration Trial in Chronic Kidney Disease Patients for HEPLISAVTM Hepatitis B Vaccine
Sep 29, 2009
PDF 10.7 KB Add to Briefcase
View Summary Dynavax Announces HEPLISAVTM Data to Be Presented at IDSA Medical Conference
Sep 22, 2009
PDF 7.8 KB Add to Briefcase
View Summary Dynavax Reports FDA Removes Clinical Hold on HEPLISAVTM Phase 3 Hepatitis B Vaccine
Sep 10, 2009
PDF 10.0 KB Add to Briefcase
View Summary Dynavax Announces European Development Strategy for HEPLISAV Hepatitis B Vaccine
Aug 12, 2009
PDF 9.2 KB Add to Briefcase
View Summary Dynavax Announces Retirement of Chief Financial Officer
Aug 7, 2009
PDF 7.5 KB Add to Briefcase
View Summary Dynavax Announces Second Quarter 2009 Financial Results
Aug 4, 2009
PDF 22.1 KB Add to Briefcase
View Summary Dynavax Announces Path for HEPLISAVTM Hepatitis B Vaccine Development
Aug 4, 2009
PDF 9.9 KB Add to Briefcase
View Summary Dynavax Presents Additional Phase 3 Data for HEPLISAVTM Hepatitis B Vaccine at DDW Medical Conference
Jun 3, 2009
PDF 13.2 KB Add to Briefcase
Showing 1-20 of 205 Page: 1 2 3 ... 11  Next 20
=add release to Briefcase